台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效

易威

(1799)
  • 股價
    91.8
  • 漲跌
    ▲0.9
  • 漲幅
    +0.99%
  • 成交量
    337
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/05/17 ~ 2024/05/31     後一日»

券商獲利排行 - 2024/05/17 ~ 2024/05/31

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.66%2,038.71,807.1231.747582535092.991.396.591.8
  9.02%1,849.9588.21,261.7-1486120998.290.7100.391.8
  7.12%1,599.8568.91,030.9-169652349689.197.991.8
  2.85%1,575.31,629-53.712959046193.892.295.891.8
  3.23%1,533.11,413.7119.4-6844851692.190.493.691.8
  6.49%1,506.825.61,481.2-23432379889.698.191.8
  7.76%704.7676.428.4-118910090.886.894.491.8
  6.65%64155.4585.7-9549997.484.19891.8
  6.73%585.950.2535.7-8278997.891.298.391.8
  9.67%440.2428.511.7-6455189.384.293.791.8
  3.73%405.3417.8-12.5811410695.393.497.391.8
  1.76%368.6426.3-57.72422019695.294.296.491.8
  3.77%367.1376.5-9.4121039194.592.696.791.8
  3.39%314.930.8284.1-67309795.8959691.8
  1.71%307.950.9257-176181949390.493.391.8
  8.36%282.9274.68.32373591.587.795.591.8
  1.84%255.30255.3-148014893.5093.591.8
  4.39%23915287-1045559997.1100.591.8
  7.44%222.64218.6-2733099.898.699.991.8
  5.47%194.555.1139.4-2611379692.297.291.8
  6.70%191.20191.2-2802998.485.498.491.8
  11.62%186.633.7152.91220880.379.183.391.8
  1.12%181232.4-51.44517312793.792.994.791.8
  5.05%178.899.279.627391290.888.997.191.8
  2.24%176.32.3174.1-8318493.991.693.991.8
  1.69%16199.961-198210194.593.89591.8
  3.89%159.2123.835.47463888.987.490.691.8
  2.86%155.9-3.3159.3-29275697.397.497.391.8
  18.76%15342.6110.4810281.67899.391.8
  5.70%143.22.4140.82629286.786.687.891.8
  6.03%134.613121.6-202239791.197.691.8
  3.54%131.946.285.7-3464093.386.694.391.8
  9.77%128.3128.300141493.889.298.391.8
  6.14%126.20126.2-2102197.8097.891.8
  5.54%124.649.175.52125489.988.2100.591.8
  1.75%123.844.579.3-30457594.193.594.491.8
  10.92%121107.113.9312992.387.299.191.8
  5.66%116.912.6104.3-1562198.396.798.891.8
  4.19%116.477.938.56322686.785.488.491.8
  1.74%113.289.224-4636895.995.296.691.8
  6.69%112.837.375.51619388.887.199.591.8
  3.99%109.910.899.1-281299584.595.391.8
  6.12%109.922.487.5-1081899.797.8100.691.8
  9.20%105.357.348-751295.487.298.791.8
  3.73%104.7118.2-13.54292496.894.599.491.8
  8.00%101.631.769.9-941397.791.699.691.8
  5.10%94.382.611.75201492.389.995.891.8
  4.57%93.935.558.41523789.488.193.291.8
  8.47%89.989.900111196.592.4100.691.8
  1.34%89.95.284.7-31407194.594.494.591.8

券商虧損排行 - 2024/05/17 ~ 2024/05/31

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.71%-4,203.83.6-4,207.4547548199.599.5103.191.8
  -8.94%-1,539.2-1,516.9-22.46919712787.492.180.291.8
  -9.23%-911.2-67.5-843.7-1061111784.49083.891.8
  -2.68%-774.7-37.2-737.52903071794.294.392.291.8
  -7.94%-644.6-602-42.65847996.6100.392.791.8
  -9.73%-612.2-179.2-433-57167386.295.484.291.8
  -7.82%-573.6-28-545.67174399.199.590.291.8
  -5.28%-548.2-470.8-77.4-446811292.6979091.8
  -5.98%-542.2-72.3-469.98594896.597.388.291.8
  -4.18%-537.9-77.3-460.61161351995.395.891.791.8
  -14.58%-503-42.4-460.6-3764380.286.479.491.8
  -17.74%-449.3-408.3-416282290.598.680.191.8
  -16.20%-437.1-13.5-423.6-3313479.492.57991.8
  -2.39%-405.3-42115.8-1116818094.395.693.191.8
  -12.65%-306-223.8-82.11226149398.682.791.8
  -2.24%-303.3-77.9-225.4691437394.7959491.8
  -2.54%-268.7-101.1-167.6-615711889.690.889.191.8
  -5.60%-260.5-12-248.44748196.897.185.191.8
  -3.93%-259.4-155.7-103.720694995.79793.891.8
  -1.58%-252.1-304.252.1-1415116596.597.595.591.8
  -4.52%-233.314.8-248.14653697.397.199.691.8
  -9.20%-210.7-197.5-13.2-3222591.696.487.491.8
  -1.53%-188.30-188.3-135013690.49790.491.8
  -2.98%-175.4-115.8-59.621634293.594.691.991.8
  -12.99%-164.40-164.412120105.5105.5091.8
  -2.84%-160.80-160.86060094.594.5091.8
  -4.31%-153-157.64.6-1353698.6100.996.491.8
  -8.84%-138.7-139.30.70181787.191.182.991.8
  -3.81%-132.8-41.2-91.72737994.195.190.591.8
  -4.78%-128.90-128.92828096.496.4091.8
  -6.66%-123.5-21.7-101.81519497.698.693.291.8
  -2.78%-121.6-51.6-70-21274989.390.588.691.8
  -3.17%-118.7-137.919.2-8313996.198.694.291.8
  -3.05%-114.3-2.2-112.1-4114289.191.389.191.8
  -5.48%-113-50.7-62.4-1672389.795.187.991.8
  -3.00%-109.5-12515.5-5323896.298.394.491.8
  -2.80%-108.3-77.6-30.718422392.293.49091.8
  -5.53%-108-27.9-80.1-1932288.796.987.691.8
  -3.52%-107.47.6-11518311398.498.298.891.8
  -4.64%-105.210.2-115.41823598.698.2100.291.8
  -9.36%-103.3-72.1-31.361259296.381.991.8
  -19.42%-101.6-77-24.6-24687.298.879.591.8
  -1.52%-99.1-25.6-73.644702693.293.592.591.8
  -1.66%-98.535.7-134.2-50176788.78789.191.8
  -5.48%-96.9-48.9-485181298.299.895.791.8
  -13.06%-94-80.9-13.13859096.28091.8
  -3.38%-86.80-86.82627095959991.8
  -5.98%-86.4-32.1-54.3915696.397.892.591.8
  -7.48%-83.10-83.1-1301385.4085.491.8
  -6.98%-82.70-82.71212098.798.7091.8
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音